Results 11 to 20 of about 2,051,960 (424)

Semaglutide in Overweight and Obese patients: Cardiovascular and/or Renal Metabolic Benefits

Revista Colombiana de Nefrología, 2022
We have read the article published by Kadowaki, et al. 1 “Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes mellitus in an East Asian population (STEP 6): A randomized, double blind, double dummy, placebo ...
Jorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Jose Cabrales, Juan Diego Montejo-Hernández   +3 more
doaj   +1 more source

Interactions between hypertension and inflammatory tone and the effect on blood pressure and outcomes in patients with COVID‐19

The Journal of Clinical Hypertension, 2021
Arterial hypertension represented one of the most common comorbidities in patients with COVID‐19. However, the impact of hypertension on outcome in COVID‐19 patients is not clear.
Jacques Amar, Nicolas Touront, Antoine M. Ciron, Caroline Pendaries   +3 more
doaj   +1 more source

Impact of concomitant COVID-19 on the outcome of patients with acute myocardial infarction undergoing coronary artery angiography

Frontiers in Cardiovascular Medicine, 2022
BackgroundThe impact of COVID-19 on the outcome of patients with MI has not been studied widely. We aimed to evaluate the relationship between concomitant COVID-19 and the clinical course of patients admitted due to acute myocardial infarction (MI ...
Michał Terlecki, Wiktoria Wojciechowska, Marek Klocek, Agnieszka Olszanecka, Adam Bednarski, Tomasz Drożdż, Christopher Pavlinec, Paweł Lis, Maciej Zając, Jakub Rusinek, Zbigniew Siudak, Stanisław Bartuś, Marek Rajzer   +12 more
doaj   +1 more source

Arterial Hypertension [PDF]

Deutsches Ärzteblatt international, 2018
Essential arterial hypertension is one of the main treatable cardiovascular risk factors. In Germany, approximately 13% of women and 18% of men have uncontrolled high blood pressure (≥ 140/90 mmHg).This review is based on pertinent publications retrieved by a selective literature search in PubMed.Arterial hypertension is diagnosed when repeated ...
Jordan, Jens, Kurschat, Christine, Reuter, Hannes   +2 more
openaire   +5 more sources

Outcome in Elderly Patients with Anca – Associated Glomerulonephritis Managed with Immunosuppressive Treatment

Acta Clinica Croatica, 2021
The most common cause of rapidly progressive glomerulonephritis in elderly, antineutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN), demands immunosuppressive therapy (IS) regimen in a multi-morbid disease burdened population.
Karlo Kurtov, Mario Laganović, Sandra Karanović, Živka Dika, Ema Ivandić, Marijana Živko, Jelena Kos, Margareta Fištrek, Bojan Jelaković, Ivana Vuković Brinar   +9 more
doaj   +1 more source

Application value of contrast‐enhanced ultrasound in preoperative localization of microwave ablation for primary hyperparathyroidism

Journal of Applied Clinical Medical Physics, Volume 23, Issue 12, December 2022., 2022
Abstract Background Ultrasonography (US) and 99mTechnetium‐sestamibi scintigraphy (99mTc‐MIBI) are currently first‐line imaging modalities to localize parathyroid adenomas with sensitivities of 80% and 84%, respectively. Therefore, finding other modalities to further improve the diagnostic accuracy for preoperative localization is critically needed ...
Fangyi Liu, Li Zang, Yunlin Li, Zhiwei Guan, Yang Liu, Xiaoling Yu, Zhiyu Han, Ping Liang   +7 more
wiley   +1 more source

Sex differences in arterial hypertension

European Heart Journal, 2022
Graphical Abstract Graphical Abstract Sex differences in hypertension. BP, blood pressure; CV, cardiovascular; T2D, type 2 diabetes; OSAS, obstructive sleep apnoea syndrome; LVH, left ventricular hypertrophy; LV, left ventricular; LA left atrial; HFpEF ...
E. Gerdts, I. Sudano, S. Brouwers, C. Borghi, R. Bruno, C. Ceconi, V. Cornelissen, F. Diévart, M. Ferrini, T. Kahan, M. Løchen, A. Maas, F. Mahfoud, A. Mihailidou, T. Moholdt, G. Parati, G. de Simone   +16 more
semanticscholar   +1 more source

Pulmonary arterial hypertension [PDF]

Orphanet Journal of Rare Diseases, 2013
Abstract Pulmonary arterial hypertension (PAH) is a chronic and progressive disease leading to right heart failure and ultimately death if untreated. The first classification of PH was proposed in 1973. In 2008, the fourth World Symposium on PH held in Dana Point (California, USA) revised previous classifications.
Montani, David, Günther, Sven, Dorfmüller, Peter, Perros, Frédéric, Girerd, Barbara, Garcia, Gilles, Jaïs, Xavier, Savale, Laurent, Artaud-Macari, Elise, Price, Laura, Humbert, Marc, Simonneau, Gérald, Sitbon, Olivier   +12 more
openaire   +5 more sources

Sotatercept for the Treatment of Pulmonary Arterial Hypertension.

New England Journal of Medicine, 2021
BACKGROUND Pulmonary arterial hypertension is characterized by pulmonary vascular remodeling, cellular proliferation, and poor long-term outcomes.
M. Humbert, V. McLaughlin, J. Gibbs, M. Gomberg-Maitland, M. Hoeper, I. Preston, R. Souza, A. Waxman, P. Escribano Subías, J. Feldman, G. Meyer, D. Montani, K. Olsson, S. Manimaran, J. Barnes, P. Linde, J. de Oliveira Pena, D. Badesch   +17 more
semanticscholar   +1 more source

Prevalence and clinical implications of atrial fibrillation in patients hospitalized due to COVID-19: Data from a registry in Poland

Frontiers in Cardiovascular Medicine, 2023
BackgroundAtrial fibrillation (AF) is a common arrhythmia with increasing prevalence with respect to age and comorbidities. AF may influence the prognosis in patients hospitalized with Coronavirus disease 2019 (COVID-19).
Michał Terlecki, Wiktoria Wojciechowska, Marek Klocek, Tomasz Drożdż, Maryla Kocowska-Trytko, Paweł Lis, Christopher Pavlinec, Jan W. Pęksa, Michał Kania, Zbigniew Siudak, Andrzej Januszewicz, Reinhold Kreutz, Maciej Małecki, Tomasz Grodzicki, Marek Rajzer, CraCov HHS Investigators   +15 more
doaj   +1 more source